Commit To Buy Capricor Therapeutics At $3, Earn 69.5% Annualized Using Options
Investors considering a purchase of Capricor Therapeutics Inc (Symbol: CAPR) shares, but cautious about paying the going market price of $6.33/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.